APAP 325 MG / benzhydrocodone 4.08 MG Oral Tablet [Apadaz]
- RxCUI
- 2118730
- RxNorm name
- APAP 325 MG / benzhydrocodone 4.08 MG Oral Tablet [Apadaz]
- Display name
- APAP 325 MG / benzhydrocodone 4.08 MG Oral Tablet [Apadaz]
- Full name
- APAP 325 MG / benzhydrocodone 4.08 MG Oral Tablet [Apadaz]
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| APADAZ | BENZHYDROCODONE AND ACETAMINOPHEN | Zevra Therapeutics, Inc. | 0590d4e5-7107-4015-a6a8-deac14265aa2 | 2025-01-07 | Boxed warning, Warnings, Adverse reactions | 2118730 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0590d4e5-7107-4015-a6a8-deac14265aa2 | apadaz 4.08 MG / 325 MG Oral Tablet [PSN] · acetaminophen 325 MG / benzhydrocodone 4.08 MG Oral Tablet [Apadaz] [SBD] · Apadaz 4.08 MG / 325 MG Oral Tablet [SY] · APAP 325 MG / benzhydrocodone 4.08 MG Oral Tablet [Apadaz] [SY] | 4 | 5 | These highlights do not include all the information needed to use APADAZ® safely and effectively. See full prescribing information for APADAZ. APADAZ (benzhydrocodone and acetaminophen) tablets, for oral use, CII Initial U.S. Approval: 1982 | 20250107 |